Vivani Medical (VANI) Competitors $1.11 -0.04 (-3.48%) Closing price 04:00 PM EasternExtended Trading$1.11 +0.00 (+0.36%) As of 04:43 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock VANI vs. AVR, RCEL, NVRO, ELMD, PROF, INGN, BWAY, LAKE, DRTS, and LNSRShould you be buying Vivani Medical stock or one of its competitors? The main competitors of Vivani Medical include Anteris Technologies Global (AVR), AVITA Medical (RCEL), Nevro (NVRO), Electromed (ELMD), Profound Medical (PROF), Inogen (INGN), BrainsWay (BWAY), Lakeland Industries (LAKE), Alpha Tau Medical (DRTS), and LENSAR (LNSR). These companies are all part of the "medical equipment" industry. Vivani Medical vs. Anteris Technologies Global AVITA Medical Nevro Electromed Profound Medical Inogen BrainsWay Lakeland Industries Alpha Tau Medical LENSAR Vivani Medical (NASDAQ:VANI) and Anteris Technologies Global (NASDAQ:AVR) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their community ranking, institutional ownership, valuation, earnings, profitability, analyst recommendations, dividends, media sentiment and risk. Do insiders and institutionals have more ownership in VANI or AVR? 6.8% of Vivani Medical shares are held by institutional investors. 44.3% of Vivani Medical shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Does the MarketBeat Community favor VANI or AVR? Vivani Medical and Anteris Technologies Global both received 4 outperform votes by MarketBeat users. CompanyUnderperformOutperformVivani MedicalOutperform Votes4100.00% Underperform VotesNo VotesAnteris Technologies GlobalOutperform Votes4100.00% Underperform VotesNo Votes Do analysts rate VANI or AVR? Vivani Medical presently has a consensus target price of $4.00, indicating a potential upside of 247.83%. Anteris Technologies Global has a consensus target price of $16.50, indicating a potential upside of 292.86%. Given Anteris Technologies Global's higher possible upside, analysts clearly believe Anteris Technologies Global is more favorable than Vivani Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Vivani Medical 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Anteris Technologies Global 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media refer more to VANI or AVR? In the previous week, Vivani Medical had 7 more articles in the media than Anteris Technologies Global. MarketBeat recorded 12 mentions for Vivani Medical and 5 mentions for Anteris Technologies Global. Anteris Technologies Global's average media sentiment score of 0.66 beat Vivani Medical's score of 0.41 indicating that Anteris Technologies Global is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Vivani Medical 1 Very Positive mention(s) 3 Positive mention(s) 4 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral Anteris Technologies Global 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Is VANI or AVR more profitable? Anteris Technologies Global's return on equity of 0.00% beat Vivani Medical's return on equity.Company Net Margins Return on Equity Return on Assets Vivani MedicalN/A -102.42% -49.21% Anteris Technologies Global N/A N/A N/A Which has stronger valuation & earnings, VANI or AVR? Anteris Technologies Global has higher revenue and earnings than Vivani Medical. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVivani MedicalN/AN/A-$25.65M-$0.45-2.56Anteris Technologies Global$2.71M55.81N/AN/AN/A SummaryAnteris Technologies Global beats Vivani Medical on 6 of the 9 factors compared between the two stocks. Remove Ads Get Vivani Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for VANI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VANI vs. The Competition Export to ExcelMetricVivani MedicalElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$68.12M$3.25B$5.65B$8.06BDividend YieldN/A1.62%4.57%4.01%P/E Ratio-2.5614.8923.1719.03Price / SalesN/A42.73385.1993.17Price / CashN/A44.0938.1634.64Price / Book2.803.456.944.33Net Income-$25.65M$89.74M$3.20B$247.06M7 Day Performance5.50%-1.19%-2.29%-0.37%1 Month Performance3.60%-10.48%2.88%-3.85%1 Year Performance-37.84%-19.34%10.82%1.27% Vivani Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VANIVivani Medical2.9965 of 5 stars$1.11-3.5%$4.00+260.4%-37.8%$65.75MN/A-2.4720Analyst ForecastNews CoverageAVRAnteris Technologies GlobalN/A$6.72-2.0%$16.50+145.5%N/A$242.08M$2.71M0.00138News CoverageRCELAVITA Medical1.6283 of 5 stars$9.03+5.6%$17.25+91.0%-44.1%$236.75M$64.25M-3.78130Short Interest ↑NVRONevro0.8922 of 5 stars$5.79-0.3%$6.43+11.1%-59.5%$221.98M$408.52M-3.061,215High Trading VolumeELMDElectromed1.0968 of 5 stars$24.78+0.6%$38.00+53.3%+45.5%$212.04M$59.63M33.04160Analyst DowngradePROFProfound Medical2.1784 of 5 stars$6.81-2.0%$14.25+109.3%-25.2%$204.57M$10.68M-5.08150INGNInogen2.9402 of 5 stars$7.50+0.7%$7.00-6.7%-10.4%$198.98M$335.71M-3.331,030BWAYBrainsWay2.7374 of 5 stars$10.21flat$13.17+29.0%+83.0%$192.22M$41.02M102.11120Short Interest ↑Gap DownLAKELakeland Industries4.7978 of 5 stars$19.93-0.8%$28.33+42.2%+25.4%$189.32M$151.82M-221.441,800Analyst UpgradeNews CoverageDRTSAlpha Tau Medical1.8641 of 5 stars$2.66+0.4%$8.00+200.8%-9.8%$186.00MN/A-6.1980Short Interest ↑LNSRLENSAR0.7147 of 5 stars$15.58+3.0%$16.00+2.7%+276.1%$183.67M$53.49M-10.67110Positive NewsGap UpHigh Trading Volume Remove Ads Related Companies and Tools Related Companies AVR Competitors RCEL Competitors NVRO Competitors ELMD Competitors PROF Competitors INGN Competitors BWAY Competitors LAKE Competitors DRTS Competitors LNSR Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:VANI) was last updated on 3/28/2025 by MarketBeat.com Staff From Our PartnersElon Warns: Exec Order 14024 Targets DollarExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredDo this Before Elon's Reveal on April 23rdElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredTrump’s Treasure Map [Pic inside]We were shown this map by former Presidential Advisor, Jim Rickards, one of the most politically connected men...Paradigm Press | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredTwo Unmistakable Patterns Return…The signs suggest we're entering one of those rare periods now. That's why Central Banks are buying gold at...Golden Portfolio | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vivani Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vivani Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
